Natick, Mass.-based medical device giant Boston Scientific Corp. hits one of the world’s fastest-growing markets with two of its drug-eluting stents, Promus and Taxus. Boston Scientific Corp.

The Bermuda Stock Exchange has been cited for its 2023 record $60 billion market in insurance-linked securities, before slipping off the pace last year. But ILS Market authority Artemis also ...

The latest price target for Boston Scientific (NYSE:BSX) was reported by UBS on October 23, 2025. The analyst firm set a price target for $140.00 expecting BSX to rise to within 12 months (a possible ...

Emerging markets remain a vital growth engine for Boston Scientific Corporation BSX, anchoring the company’s broader international strategy and long-term expansion plans. In the first quarter of 2025, ...